Market forces rained on the parade of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shareholders today, when the covering analyst downgraded their forecasts for next year. NasdaqGS:CPIX Earnings and Revenue Growth November 19th 2020 The consensus price target fell 13% to US$8.50, with the analyst clearly concerned about the company following the weaker revenue and earnings outlook. Both revenue and earnings per share (EPS) estimates were cut sharply as the analyst factored in the latest outlook for the business, concluding that they were too optimistic previously.